{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:23:52Z","timestamp":1793726632876,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870885, 81672203, 81600975"],"award-info":[{"award-number":["81870885, 81672203, 81600975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2019M651530"],"award-info":[{"award-number":["2019M651530"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A growing body of studies have indicated that bone marrow mesenchymal stem cells (BMSCs) have powerful analgesic effects in animal models of bone cancer pain. Here, we explored the molecular mechanisms underlying how BMSCs alleviate pain sensation in a mouse model of bone cancer pain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>C3H\/HeN adult male mice were used to generate a bone cancer pain model. BMSCs were isolated from mouse bone marrow, modified by transfection with microRNA-9-5p (miR-9-5p), and infused into the spinal cord. Spontaneous flinches, paw withdrawal latency, limb-use score, and weight-bearing score were used to assess pain-related behaviors. ELISA, RT-PCR, western blot, and luciferase assay were used to assess gene expressions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our results show that miR-9-5p regulated the expression of both repressor element silencing transcription factor (REST) and \u03bc-opioid receptors (MOR) by targeting REST in primary mouse BMSCs. Overexpression of miR-9-5p reversed the activation of inflammatory pathway in TNF-\u03b1- and IL-6-treated BMSCs. In addition, miR-9-5p modified BMSCs alleviated cancer pain in the sarcoma-inoculated mouse model. MiR-9-5p modified BMSCs suppressed cytokine expression in the spinal cord of sarcoma-inoculated mice by suppressing REST gene expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results indicate that miR-9-5p modified BMSCs can relieve bone cancer pain via modulating neuroinflammation in the central nervous system, suggesting genetically modified BMSCs could be a promising cell therapy in pain management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-020-01765-w","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T12:05:01Z","timestamp":1584360301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antinociceptive effect of intrathecal injection of miR-9-5p modified mouse bone marrow mesenchymal stem cells on a mouse model of bone cancer pain"],"prefix":"10.1186","volume":"17","author":[{"given":"Chao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zude","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/SPC.0000000000000261","volume":"11","author":"J Haumann","year":"2017","unstructured":"Haumann J, Joosten EBA, Everdingen M. Pain prevalence in cancer patients: status quo or opportunities for improvement? Curr Opin Support Palliat Care. 2017;11:99\u2013104.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1765_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manag. 2016;51:1070\u201390 e1079.","journal-title":"J Pain Symptom Manag"},{"key":"1765_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/SPC.0000000000000048","volume":"8","author":"PW Mantyh","year":"2014","unstructured":"Mantyh PW. Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care. 2014;8:83\u201390.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1765_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejca.2016.10.021","volume":"71","author":"R von Moos","year":"2017","unstructured":"von Moos R, Costa L, Ripamonti CI, Niepel D, Santini D. Improving quality of life in patients with advanced cancer: targeting metastatic bone pain. Eur J Cancer. 2017;71:80\u201394.","journal-title":"Eur J Cancer"},{"key":"1765_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jpainsymman.2007.01.001","volume":"33","author":"J Gralow","year":"2007","unstructured":"Gralow J, Tripathy D. Managing metastatic bone pain: the role of bisphosphonates. J Pain Symptom Manag. 2007;33:462\u201372.","journal-title":"J Pain Symptom Manag"},{"key":"1765_CR6","doi-asserted-by":"publisher","first-page":"004","DOI":"10.1016\/j.jbo.2018.10.004","volume":"15","author":"S D'Oronzo","year":"2019","unstructured":"D'Oronzo S, Coleman R, Brown J, Silvestris F. Metastatic bone disease: pathogenesis and therapeutic options: up-date on bone metastasis management. J Bone Oncol. 2019;15:004.","journal-title":"J Bone Oncol"},{"key":"1765_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40005-017-0381-1","volume":"48","author":"SB Yong","year":"2018","unstructured":"Yong SB, Chung JY, Song Y, Kim YH. Recent challenges and advances in genetically-engineered cell therapy. J Pharm Investig. 2018;48:199\u2013208.","journal-title":"J Pharm Investig"},{"key":"1765_CR8","doi-asserted-by":"crossref","unstructured":"Rossi F, Tortora C, Punzo F, Bellini G, Argenziano M, Di Paola A, Torella M, Perrotta S. The endocannabinoid\/endovanilloid system in bone: from osteoporosis to osteosarcoma. Int J Mol Sci. 2019;20:E1919.","DOI":"10.3390\/ijms20081919"},{"key":"1765_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.20344\/amp.5801","volume":"28","author":"P Reis-Pina","year":"2015","unstructured":"Reis-Pina P, Lawlor PG, Barbosa A. Cancer-related pain management and the optimal use of opioids. Acta Medica Port. 2015;28:376\u201381.","journal-title":"Acta Medica Port"},{"key":"1765_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11916-018-0689-1","volume":"22","author":"S Kunnumpurath","year":"2018","unstructured":"Kunnumpurath S, Julien N, Kodumudi G, Kunnumpurath A, Kodumudi V, Vadivelu N. Global supply and demand of opioids for pain management. Curr Pain Headache Rep. 2018;22:34.","journal-title":"Curr Pain Headache Rep"},{"key":"1765_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/19336950.2015.1069450","volume":"9","author":"Y Bao","year":"2015","unstructured":"Bao Y, Gao Y, Yang L, Kong X, Yu J, Hou W, Hua B. The mechanism of mu-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence. Channels (Austin). 2015;9:235\u201343.","journal-title":"Channels (Austin)"},{"key":"1765_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2013.03.008","volume":"71","author":"C Parenti","year":"2013","unstructured":"Parenti C, Turnaturi R, Arico G, Gramowski-Voss A, Schroeder OH, Marrazzo A, Prezzavento O, Ronsisvalle S, Scoto GM, Ronsisvalle G, Pasquinucci L. The multitarget opioid ligand LP1\u2019s effects in persistent pain and in primary cell neuronal cultures. Neuropharmacology. 2013;71:70\u201382.","journal-title":"Neuropharmacology"},{"key":"1765_CR13","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1093\/nar\/gkl724","volume":"34","author":"CS Kim","year":"2006","unstructured":"Kim CS, Choi HS, Hwang CK, Song KY, Lee BK, Law PY, Wei LN, Loh HH. Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res. 2006;34:6392\u2013403.","journal-title":"Nucleic Acids Res"},{"key":"1765_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2015.12.003","volume":"625","author":"DE Willis","year":"2016","unstructured":"Willis DE, Wang M, Brown E, Fones L, Cave JW. Selective repression of gene expression in neuropathic pain by the neuron-restrictive silencing factor\/repressor element-1 silencing transcription (NRSF\/REST). Neurosci Lett. 2016;625:20\u20135.","journal-title":"Neurosci Lett"},{"key":"1765_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/j.pain.0000000000000848","volume":"158","author":"C Zhu","year":"2017","unstructured":"Zhu C, Tang J, Ding T, Chen L, Wang W, Mei XP, He XT, Wang W, Zhang LD, Dong YL, Luo ZJ. Neuron-restrictive silencer factor-mediated downregulation of mu-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain. Pain. 2017;158:879\u201390.","journal-title":"Pain"},{"issue":"10","key":"1765_CR16","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1097\/j.pain.0000000000001633","volume":"160","author":"F Zhang","year":"2019","unstructured":"Zhang F, Gigout S, Liu Y, Wang Y, Hao H, Buckley NJ, Zhang H, Wood IC, Gamper N. Repressor element 1-silencing transcription factor drives the development of chronic pain states. Pain. 2019;160(10):2398\u2013408.","journal-title":"Pain"},{"key":"1765_CR17","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1093\/bioinformatics\/btv220","volume":"31","author":"E Patrick","year":"2015","unstructured":"Patrick E, Buckley M, Muller S, Lin DM, Yang JY. Inferring data-specific micro-RNA function through the joint ranking of micro-RNA and pathways from matched micro-RNA and gene expression data. Bioinformatics. 2015;31:2822\u20138.","journal-title":"Bioinformatics"},{"key":"1765_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nprot.2008.221","volume":"4","author":"M Soleimani","year":"2009","unstructured":"Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 2009;4:102\u20136.","journal-title":"Nat Protoc"},{"key":"1765_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2017.01014","volume":"8","author":"Y Huh","year":"2017","unstructured":"Huh Y, Ji RR, Chen G. Neuroinflammation, bone marrow stem cells, and chronic pain. Front Immunol. 2017;8:1014.","journal-title":"Front Immunol"},{"key":"1765_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/mi.10.3.7","volume":"10","author":"BL Schmidt","year":"2010","unstructured":"Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL. Mechanism of cancer pain. Mol Interv. 2010;10:164\u201378.","journal-title":"Mol Interv"},{"key":"1765_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.intimp.2015.08.037","volume":"29","author":"Q Li","year":"2015","unstructured":"Li Q, Zhang X. Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal tumor necrosis factor-alpha expression in a mouse model. Int Immunopharmacol. 2015;29:818\u201323.","journal-title":"Int Immunopharmacol"},{"key":"1765_CR22","doi-asserted-by":"publisher","first-page":"174480691985798","DOI":"10.1177\/1744806919857981","volume":"15","author":"D Zhao","year":"2019","unstructured":"Zhao D, Han DF, Wang SS, Lv B, Wang X, Ma C. Roles of tumor necrosis factor-alpha and interleukin-6 in regulating bone cancer pain via TRPA1 signal pathway and beneficial effects of inhibition of neuro-inflammation and TRPA1. Mol Pain. 2019;15:1744806919857981.","journal-title":"Mol Pain"},{"key":"1765_CR23","doi-asserted-by":"publisher","first-page":"19099","DOI":"10.1523\/JNEUROSCI.4852-12.2013","volume":"33","author":"Q Xu","year":"2013","unstructured":"Xu Q, Zhang XM, Duan KZ, Gu XY, Han M, Liu BL, Zhao ZQ, Zhang YQ. Peripheral TGF-beta1 signaling is a critical event in bone cancer-induced hyperalgesia in rodents. J Neurosci. 2013;33:19099\u2013111.","journal-title":"J Neurosci"},{"key":"1765_CR24","first-page":"381","volume":"3","author":"H Nersesyan","year":"2007","unstructured":"Nersesyan H, Slavin KV. Current aproach to cancer pain management: availability and implications of different treatment options. Ther Clin Risk Manag. 2007;3:381\u2013400.","journal-title":"Ther Clin Risk Manag"},{"key":"1765_CR25","unstructured":"Apkhazava M, Kvachadze I, Tsagareli M, Mzhavanadze D, Chakhnashvili M. The relationship between thermal pain sensation, free testosterone, Trpv1, Mor levels and various degrees of hostility in young healthy males. Georgian Med News. 2018;283:109\u201314."}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01765-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-020-01765-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01765-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:55:51Z","timestamp":1615856151000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-01765-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-01765-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"18 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental approaches were reviewed and approved by the Animal Use and Care Committee in Renji Hospital, School of Medicine, Shanghai Jiao Tong University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}